|  | | | Review | Top |  | Gene expression analysis in RA: towards personalized medicine OPENA N Burska, K Roget, M Blits, L Soto Gomez, F van de Loo, L D Hazelwood, C L Verweij, A Rowe, G N Goulielmos, L G M van Baarsen and F Ponchel Pharmacogenomics J 2014 14: 93-106; advance online publication, March 4, 2014; 10.1038/tpj.2013.48 Abstract | Full Text |  | Original Articles | Top |  | Functional characterization of 32 CYP2C9 allelic variantsY Niinuma, T Saito, M Takahashi, C Tsukada, Mi Ito, N Hirasawa and M Hiratsuka Pharmacogenomics J 2014 14: 107-114; advance online publication, June 11, 2013; 10.1038/tpj.2013.22 Abstract | Full Text |  |  |  | The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancerM M Hagleitner, M J H Coenen, R Aplenc, A Patiño-Garcia, P Chiusolo, D Gemmati, M De Mattei, A Ongaro, M Krajinovic, P M Hoogerbrugge, S H H M Vermeulen and D M W M te Loo Pharmacogenomics J 2014 14: 115-119; advance online publication, May 7, 2013; 10.1038/tpj.2013.19 Abstract | Full Text |  |  |  | Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians OPENX Liu, D Cheng, Q Kuang, G Liu and W Xu Pharmacogenomics J 2014 14: 120-129; advance online publication, March 26, 2013; 10.1038/tpj.2013.10 Abstract | Full Text |  |  |  | The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapyG Absenger, L Benhaim, J Szkandera, W Zhang, D Yang, M J Labonte, M Pichler, M Stotz, H Samonigg, W Renner, A Gerger and H-J Lenz Pharmacogenomics J 2014 14: 130-134; advance online publication, April 9, 2013; 10.1038/tpj.2013.15 Abstract | Full Text |  |  |  | Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapyL Benhaim, A Gerger, P Bohanes, D Paez, T Wakatsuki, D Yang, M J LaBonte, Y Ning, R El-Khoueiry, F Loupakis, W Zhang, P Laurent-Puig and H J Lenz Pharmacogenomics J 2014 14: 135-141; advance online publication, June 11, 2013; 10.1038/tpj.2013.21 Abstract | Full Text |  |  |  | Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrenceD Páez, A Gerger, W Zhang, D Yang, M J Labonte, L Benhanim, M Kahn, F Lenz, C Lenz, Y Ning, T Wakatsuki, F Loupakis and H-J Lenz Pharmacogenomics J 2014 14: 142-150; advance online publication, July 2, 2013; 10.1038/tpj.2013.20 Abstract | Full Text |  |  |  | Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependentV Michaud, Y Kreutz, T Skaar, E Ogburn, N Thong, D A Flockhart and Z Desta Pharmacogenomics J 2014 14: 151-159; advance online publication, April 30, 2013; 10.1038/tpj.2013.17 Abstract | Full Text |  |  |  | Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descentF Aminkeng, C J D Ross, S R Rassekh, L R Brunham, J Sistonen, M-P Dube, M Ibrahim, T B Nyambo, S A Omar, A Froment, J-M Bodo, S Tishkoff, B C Carleton and M R Hayden The Canadian Pharmacogenomics Network for Drug Safety Consortium Pharmacogenomics J 2014 14: 160-170; advance online publication, April 16, 2013; 10.1038/tpj.2013.13 Abstract | Full Text |  |  |  | Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort OPENBRAGGSS: H Gaston, D Mulherin, T Price, T Sheeran, V Chalam, S Baskar, P Emery, A Morgan, M Buch, S Bingham, S O'Reilly, L Badcock, M Regan, T Ding, C Deighton, G Summers, N Raj, R Stevens, N Williams, J Isaacs, P Platt, D Walker, L Kay, B Griffiths, W-F Ng, P Peterson, A Lorenzi, H Foster, M Friswell, B Thompson, M Lee, I Griffiths, A Hassell, P Dawes, C Dowson, S Kamath, J Packham, M Shadforth, Ann Brownfield, R Williams, C Mukhtyar, B Harrison, N Snowden, S Naz, J Ledingham, R Hull, F McCrae, A Thomas, S Young Min, R Shaban, E Wong, C Kelly, C Heycock, J Hamilton, V Saravanan, G Wilson, D Bax, L Dunkley, M Akil, R Tattersall, R Kilding, S Till, J Boulton, T Tait, M Bukhari, J Halsey, L Ottewell, C Buckley, D Situnayake, D Carruthers, K Grindulis, F Khatack, S Elamanchi, K Raza, A Filer, R Jubb, R Abernathy, M Plant, S Pathare, F Clarke, S Tuck, J Fordham, A Paul, M Bridges, A Hakim, D O'Reilly, V Rajagopal, S Bhagat, C Edwards, P Prouse, R Moitra, D Shawe, A Bamji, P Klimiuk, A Bowden, W Mitchell, I Bruce, A Barton, R Gorodkin, P Ho, K Hyrich, W Dixon, A Rai, G Kitas, N Erb, R Klocke, K Douglas, A Pace, R Sandhu, A Whallett, F Birrell, M Allen, K Chaudhuri, C Chattopadhyay, J McHale, A Jones, A Gupta, I Pande, I Gaywood, P Lanyon, P Courtney, M Doherty, H Chinoy, T O'Neill, A Herrick, A Jones, R Cooper, R Bucknall, C Marguerie, S Rigby, N Dunn, S Green, A Al-Ansari, S Webber, N Hopkinson, C Dunne, B Quilty, B Szebenyi, M Green, M Quinn, A Isdale, A Brown, B Saleem, A Samanta, P Sheldon, W Hassan, J Francis, A Kinder, R Neame, A Moorthy, W Al-Allaf, A Taggart, K Fairburn, F McKenna, M Green, A Gough, C Lawson, M Piper, E Korendowych, T Jenkinson, R Sengupta, A Bhalla, N McHugh, Debbie Bond, R Luqmani, B Bowness, P Wordsworth, J David, W Smith, D Mewar, E Tunn, K Nelson, T Kennedy, J Nixon, A Woolf, M Davis, D Hutchinson, A Endean, D Coady, D Wright, C Morley, G Raftery, C Bracewell, L Kidd, I Abbas, C Filer, G Kallarackal, J Bluett, I Ibrahim, D Plant, K L Hyrich, A W Morgan, A G Wilson, J D Isaacs and A Barton Pharmacogenomics J 2014 14: 171-175; advance online publication, July 16, 2013; 10.1038/tpj.2013.26 Abstract | Full Text |  |  |  | Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorderE J Brandl, A K Tiwari, X Zhou, J Deluce, J L Kennedy, D J Müller and M A Richter Pharmacogenomics J 2014 14: 176-181; advance online publication, April 2, 2013; 10.1038/tpj.2013.12 Abstract | Full Text |  |  |  | Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS)R D Beech, J J Leffert, A Lin, L G Sylvia, S Umlauf, S Mane, H Zhao, C Bowden, J R Calabrese, E S Friedman, T A Ketter, D V Iosifescu, N A Reilly-Harrington, M Ostacher, M E Thase and A Nierenberg Pharmacogenomics J 2014 14: 182-191; advance online publication, May 14, 2013; 10.1038/tpj.2013.16 Abstract | Full Text |  |  |  | HIBAG—HLA genotype imputation with attribute bagging OPENX Zheng, J Shen, C Cox, J C Wakefield, M G Ehm, M R Nelson and B S Weir Pharmacogenomics J 2014 14: 192-200; advance online publication, May 28, 2013; 10.1038/tpj.2013.18 Abstract | Full Text |  |  |  | | Advertisement |  | 
Nature Middle East is your free news portal covering the latest research and scientific breakthroughs in the Arabic-speaking Middle East. The site has a broad scope that caters to scientific and medical researchers at all levels, from students to post-doctoral fellows to principal investigators.
Sign up for the free Nature Middle East alert today!
www.nature.com/nmiddleeast
In partnership with: KAIMRC | |
|  | | |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  |
|  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
|
No comments:
Post a Comment